Skip to content
ANAVEX
ANAVEXANAVEX
  • HOME
  • ABOUT US
  • OUR TEAM
  • PUBLICATIONS
  • INVESTORS
    • Events
    • Share Data
    • Analyst Coverage
    • Code of Conduct
    • Investor Material
    • Presentations
  • JOIN US
Search
  • HOME
  • ABOUT US
  • OUR TEAM
  • PUBLICATIONS
  • INVESTORS
    • Events
    • Share Data
    • Analyst Coverage
    • Code of Conduct
    • Investor Material
    • Presentations
  • JOIN US

Loss of sigma binding sites in the CA1 area of the anterior hippocampus in Alzheimer’s disease correlates with CA1 pyramidal cell loss.

Alzheimer's DiseaseBy alessandroOctober 1, 1993

Brain Res 623, 299-302, (1993). Jansen, K. L., Faull, R. L., Storey, P., & Leslie, R. A. View abstract in PubMed

ANAVEX

ANAVEX® is a trademark of Anavex®Life Sciences Corp. - 2017 All Rights Reserved

Go to Top
Bio CEO Investor Conference
Bio Conference Presentation
Bio CEO Investor Webcast